Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Etripamil by Milestone Pharmaceuticals for Supraventricular Tachycardia: Likelihood of Approval
Etripamil is under clinical development by Milestone Pharmaceuticals and currently in Pre-Registration for Supraventricular Tachycardia. According to GlobalData, Pre-Registration drugs...
Data Insights
Risk adjusted net present value: What is the current valuation of Milestone Pharmaceuticals's Etripamil?
Etripamil is a small molecule commercialized by Milestone Pharmaceuticals, with a leading Pre-Registration program in Supraventricular Tachycardia. According to Globaldata,...